Cargando…

Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer

Vascular endothelial growth factor (VEGF) receptors consist of three cell-membrane type receptors (VEGFR-1, VEGFR-2 and VEGFR-3), and soluble form of VEGFR-1 (sVEGFR-1), an intrinsic negative counterpart of the VEGF. In this study, we measured intratumoral protein levels of free and total VEGF, VEGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Bando, H, Weich, H A, Brokelmann, M, Horiguchi, S, Funata, N, Ogawa, T, Toi, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362070/
https://www.ncbi.nlm.nih.gov/pubmed/15668703
http://dx.doi.org/10.1038/sj.bjc.6602374
_version_ 1782153371024621568
author Bando, H
Weich, H A
Brokelmann, M
Horiguchi, S
Funata, N
Ogawa, T
Toi, M
author_facet Bando, H
Weich, H A
Brokelmann, M
Horiguchi, S
Funata, N
Ogawa, T
Toi, M
author_sort Bando, H
collection PubMed
description Vascular endothelial growth factor (VEGF) receptors consist of three cell-membrane type receptors (VEGFR-1, VEGFR-2 and VEGFR-3), and soluble form of VEGFR-1 (sVEGFR-1), an intrinsic negative counterpart of the VEGF. In this study, we measured intratumoral protein levels of free and total VEGF, VEGFR-2 and sVEGFR-1 from 202 primary breast cancer tissues and examined their prognostic values. A significant inverse correlation was found between free or total VEGF and oestrogen receptor (ER) status (P=0.042 and 0.032, respectively). A univariate analysis showed that low sVEGFR-1 and high total VEGF were significantly associated with poor prognosis in disease-free survival (DFS) and overall survival (OS). The ratio of sVEGFR-1 to total VEGF was a strong prognostic indicator (DFS: P=0.008; OS: P=0.0002). A multivariate analysis confirmed the independent prognostic values of total VEGF and the ratio of sVEGFR-1 to total VEGF. In subgroup analysis, total VEGF was a significant prognostic indicator for ER-positive tumours but not for ER-negative tumours, whereas sVEGFR-1 was significant for ER-negative tumours but not for ER-positive tumours. In conclusion, the intratumoral sVEGFR-1 level, VEGF level and the ratio of sVEGFR-1 to total VEGF are potent prognostic indicators of primary breast cancer, and might be relevant to ER status.
format Text
id pubmed-2362070
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23620702009-09-10 Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer Bando, H Weich, H A Brokelmann, M Horiguchi, S Funata, N Ogawa, T Toi, M Br J Cancer Molecular Diagnostics Vascular endothelial growth factor (VEGF) receptors consist of three cell-membrane type receptors (VEGFR-1, VEGFR-2 and VEGFR-3), and soluble form of VEGFR-1 (sVEGFR-1), an intrinsic negative counterpart of the VEGF. In this study, we measured intratumoral protein levels of free and total VEGF, VEGFR-2 and sVEGFR-1 from 202 primary breast cancer tissues and examined their prognostic values. A significant inverse correlation was found between free or total VEGF and oestrogen receptor (ER) status (P=0.042 and 0.032, respectively). A univariate analysis showed that low sVEGFR-1 and high total VEGF were significantly associated with poor prognosis in disease-free survival (DFS) and overall survival (OS). The ratio of sVEGFR-1 to total VEGF was a strong prognostic indicator (DFS: P=0.008; OS: P=0.0002). A multivariate analysis confirmed the independent prognostic values of total VEGF and the ratio of sVEGFR-1 to total VEGF. In subgroup analysis, total VEGF was a significant prognostic indicator for ER-positive tumours but not for ER-negative tumours, whereas sVEGFR-1 was significant for ER-negative tumours but not for ER-positive tumours. In conclusion, the intratumoral sVEGFR-1 level, VEGF level and the ratio of sVEGFR-1 to total VEGF are potent prognostic indicators of primary breast cancer, and might be relevant to ER status. Nature Publishing Group 2005-02-14 2005-01-25 /pmc/articles/PMC2362070/ /pubmed/15668703 http://dx.doi.org/10.1038/sj.bjc.6602374 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular Diagnostics
Bando, H
Weich, H A
Brokelmann, M
Horiguchi, S
Funata, N
Ogawa, T
Toi, M
Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
title Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
title_full Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
title_fullStr Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
title_full_unstemmed Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
title_short Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
title_sort association between intratumoral free and total vegf, soluble vegfr-1, vegfr-2 and prognosis in breast cancer
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362070/
https://www.ncbi.nlm.nih.gov/pubmed/15668703
http://dx.doi.org/10.1038/sj.bjc.6602374
work_keys_str_mv AT bandoh associationbetweenintratumoralfreeandtotalvegfsolublevegfr1vegfr2andprognosisinbreastcancer
AT weichha associationbetweenintratumoralfreeandtotalvegfsolublevegfr1vegfr2andprognosisinbreastcancer
AT brokelmannm associationbetweenintratumoralfreeandtotalvegfsolublevegfr1vegfr2andprognosisinbreastcancer
AT horiguchis associationbetweenintratumoralfreeandtotalvegfsolublevegfr1vegfr2andprognosisinbreastcancer
AT funatan associationbetweenintratumoralfreeandtotalvegfsolublevegfr1vegfr2andprognosisinbreastcancer
AT ogawat associationbetweenintratumoralfreeandtotalvegfsolublevegfr1vegfr2andprognosisinbreastcancer
AT toim associationbetweenintratumoralfreeandtotalvegfsolublevegfr1vegfr2andprognosisinbreastcancer